Re: Ten Herbs Used for Glycemic Control in Type 2 Diabetes
Karel R. Ten herbs for glycemic control in type 2 diabetes. J Am Herbalists Guild. 2009;8(2): 53-63.
Diabetes mellitus affects
nearly 24 million people in the United
States. According to the National Diabetes Information
Clearinghouse, 90-95% of diabetics have type 2 diabetes. Managing type 2
diabetes requires the maintenance of glycemic control, treatment of comorbidities,
and prevention of vascular complications. This article focuses on the use of 10
particular herbs for glycemic control.
Conventional medications,
including insulin, may allow persons with type 2 diabetes to live relatively
normal lives, says the author. If there is no permanent pancreatic beta-cell
dysfunction, however, type 2 diabetes may be reversed with appropriate dietary
and lifestyle modifications and the adjunctive use of medicinal herbs and
supplements. Dietary changes should include an increased intake of high-quality
protein and high-fiber carbohydrates and a decreased intake of refined
carbohydrates and saturated fats. Many herbs help enhance insulin sensitivity
and glycemic control. In addition to those herbs focused specifically on
glycemic control, herbs including vascular tonics, antioxidants, adaptogens,
and circulatory stimulants may help decrease some of the complications.
Ivy gourd (Coccinia grandis syn. C. indica), a traditional Ayurvedic
herb, is widely and safely used in India as a traditional treatment
for diabetes. Clinical trials are cited that support its efficacy and
therapeutic benefits. Its mechanisms of action are poorly understood, says the
author, but appear to involve insulin-mimetic properties.
Evidence suggests that Asian ginseng
(Panax ginseng) improves glucose
transport, facilitating the movement of glucose across apical membranes into
cells, and potentiates the effects of endogenous or administered insulin via
insulin-sparing activity. Among the studies cited by the author is a trial on Asian
ginseng's safety and efficacy in a cohort of healthy individuals with
controlled type 2 diabetes; adjunctive Asian ginseng improved plasma glucose
and plasma insulin levels but there was no reduction in hemoglobin A1c. Other
cited research supports ginseng's use as an adjunctive antiglycemic.
American ginseng (P. quinquefolius) has been shown to
decrease fasting blood glucose and hemoglobin A1c in clinical trials cited by
the author. In vitro research suggests that American ginseng acts to increase
insulin production and decrease its breakdown via pancreatic beta cells by
preventing beta cell apoptosis.1,2 Both Asian ginseng and American
ginseng contain ginsenosides, which appear to increase insulin sensitivity by acting
as ligands for peroxisome proliferator-activated receptors.3 The safety profile of American ginseng
is highly favorable, says the author, and traditional use suggests that it may
provide a less stimulating alternative to Asian ginseng for herbal therapy.
Results of clinical trials of
cinnamon (Cinnamomum cassia) for
glycemic control are mixed. The author cites several clinical trials that have
reported cinnamon's antiglycemic effects and states that the precise mechanism
by which it exerts those effects is "imprecisely understood." The
herb is well tolerated and safe.
A number of animal trials
have found that garlic (Allium sativum)
administration resulted in dramatic decreases in blood glucose levels, while
other trials indicated no antiglycemic activity; similar conflicting results
have been reported in clinical trials, says the author. Those conflicting
results may involve differences in dosage, type of garlic preparation, and
experimental design. One cited human study resulted in significant reductions
in serum glucose and triglycerides, with the diabetic cohort receiving 300 mg
per day of a time-release garlic powder. If garlic is an effective clinical
antiglycemic, it may exert its effects in part by stimulating beta-cell insulin
secretion, thereby resulting in peripheral insulin-like activity.4
Dyspepsia may occur with higher doses, and consumption of more than 5 grams per
day of fresh garlic is contraindicated with the use of warfarin because of
possible potentiation of anticoagulant action.
Indian plantain (psyllium
seed; Plantago ovata) has been shown
in both animal models and human trials to significantly lower postprandial
blood glucose and insulin levels in type 2 diabetes.5,6 The author
reports that its efficacy as an antiglycemic agent has been proven at doses of
10 to 15 grams daily taken either three times a day before meals or twice a day
before breakfast and dinner. According to the author, psyllium increases
viscosity of intestinal contents and increases gastric motility. "The antiglycemic
effects are the result of both mechanisms' decreased absorption and increased
gastric emptying attendant upon greater bowel motility," writes the
author. Psyllium must be consumed with adequate water to prevent choking or
intestinal obstruction. Allergies to psyllium are rare.
Fenugreek (Trigonella foenum-graecum) has proven to
be an effective antiglycemic agent alone and in combination with other Indian
medicinal plants. It is generally well tolerated although some people may
experience flatulence and diarrhea. It is contraindicated for people allergic
to chickpeas, people with celiac disease and upper digestive tract irritation,
and those suffering from fat malabsorption or deficiencies of fat-soluble
vitamins.
Gymnema (Gymnema sylvestre) has been used traditionally to reduce sugar
cravings. According to the author, clinical trials are "extremely
encouraging, with robust improvements in glycemic control following its
use." Gymnema appears to increase the production of endogenous insulin by
pancreatic beta cells and may stimulate regeneration of remaining beta cells in
individuals who have suffered beta cell loss.7,8 Although the data
on the herb are intriguing, a few scientists have conducted most of the
research, so it is too early to state conclusively that the herb is capable of
regenerating pancreatic tissue in a clinically relevant manner.7 Its
primary safety issue is possible induction of hypoglycemia when combined with
insulin or oral diabetic agents.
Bitter melon (Momordica charantia) has exhibited
antiglycemic activity in both animal and clinical trials, says the author.
Various compounds of the herb appear to be responsible for its antiglycemic
activity, including the steroidal glycosides momordin and charantin. The
primary safety concern is that its antiglycemic activity may be additive with
conventional antiglycemic medications and may precipitate hypoglycemia.
The author cites published
controlled clinical trials on holy basil (tulsi; Ocimum tenuiflorum syn. O.
sanctum) that reported significant declines in both fasting and
postprandial glucose, with no adverse events. He also cites animal and in vitro
research supporting a therapeutic role for holy basil in diabetes generally and
for glycemic control in particular. The author discusses several mechanisms
that may be responsible for holy basil's pharmacological activity. The herb has
a long history of safe use; however, as with other herbs discussed in this
article, it may interact with conventional antiglycemic medications.
"All of the ten herbs
described have a long history of use and an exemplary safety record," says
the author. "The clinical herbalist can, with the few caveats mentioned,
feel confident when employing these medicines as part of a program of glycemic
control."
―Shari Henson
References
1Luo JZ, Luo L. American ginseng stimulates insulin
production and prevents apoptosis through regulation of uncoupling protein-2 in
cultured beta cells. Evid Based
Complement Altern Med. 2006;3:365-372.
2Wu Z, Luo JZ, Luo L. American ginseng modulates
pancreatic beta cell activities. Chin Med.
2007;2:11. Electronic journal retrieved April 16, 2008, from:
http://www.cmjournal.org/content/2/1/11.
4Liu CT, Sheen LY, Chong KL. Does garlic have a role as
an antidiabetic agent? Mol Nutr Food Res.
2007;51:1353-1364.
5Hannan JM, Ali L, Khaleque J, Akhter M, Flatt PR,
Abdel-Wahab YH. Aqueous extracts of husks of Plantago ovata reduce hyperglycemia in type 1 and type 2 diabetes
by inhibition of intestinal glucose absorption. Br J Nutr. 2006;96:131-137.
6Sierra M, Garcia J, Fernandez N, Diez M, Calle A.
Therapeutic effects of psyllium in type 2 diabetic patients. Eur J Clin Nutr. 2002;56:830-842.
7Bradley R, Oberg EB, Calabrese C, Standish LJ.
Algorithm for complementary and alternative medicine practice and research in
type 2 diabetes. J Altern Complement Med.
2007;13:159-175.
8Shanmugasundaram
ER, Gopinath KL, Shanmugasundaram KR, Rajendran VM. Possible regeneration of
the islets of Langerhans in streptozotocin-diabetic rats given Gymnema sylvestre leaf extracts. J Ethnopharmacol. 1990b;30:265-279.